))
Special Episode: Trends in drug testing resulting from the COVID-19 pandemic
已归档的系列专辑 ("不活跃的收取点" status)
When?
This feed was archived on January 03, 2024 08:08 (
Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间，但仍然无法截取有效的播客收取点
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 301225207 series 2854810
内容由questdrugtesting提供。所有播客内容（包括剧集、图形和播客描述）均由 questdrugtesting 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
The convergence of the opioid epidemic and the coronavirus disease 2019 (COVID-19) pandemic has created new healthcare challenges. Health systems, from a system- and individual clinician-level, are more important than ever in the pursuit of addressing the epidemic within the pandemic.
In this session, Dr Gudin discusses with Dr Pat Alagia on the Quest Dialogues podcast:
- Recently-published data by Quest that demonstrates decreased drug testing overall, with increased positivity for high-risk drugs and dangerous drug combinations
- Tools and practices for clinicians to assess and stratify patients for potential prescription drug abuse
- System-level strategies that employ an integrated care delivery approach, including leveraging community and diagnostics partnerships, to support impacted patient populations
----more----
About Dr Pat Alagia
As an entrepreneurial, innovative, and forward-thinking physician executive, Dr Alagia has developed extensive experience and deep expertise throughout the healthcare ecosystem through his many years in the health system C-Suite and as a Senior Executive in major medical companies. He has led large complex academically based regional healthcare systems, for-profit and not-for-profit healthcare organizations, venture capital-backed healthcare companies, and small and large clinical practices.
Today as the Chief Clinical Officer for Hospitals and Health Systems and as a Senior Medical Director for core and advanced at Quest Diagnostics, Dr Alagia and his clinical, scientific, academic, and commercial colleagues focus on a variety of topics involving diagnostic testing and patient care across the care continuum. He and his team are passionately committed to patient care, clinical and scientific excellence, and building interdisciplinary collegial relationships.
23集单集
分享
